Biogen and TheraPanacea Announce New Collaboration

Read the press release here.

 

Biogen and TheraPanacea Announce New Collaboration with the Potential to Advance Digital Health for Personalized Medicine in Neuroscience

 

  • Collaboration aims to develop innovative machine learning and artificial intelligence solutions for personalized and earlier treatment in neurology
  • Biogen to gain exclusive rights to TheraPanacea technology in neuroscience

 

CAMBRIDGE, Mass. and PARIS, Dec. 14, 2021 (GLOBE NEWSWIRE) — Biogen Inc. (Nasdaq: BIIB) and TheraPanacea today announced that they have entered into a collaboration focused on multiple therapeutic areas in neuroscience, to further build on the companies’ existing relationship. The aim is to leverage machine learning (ML) and artificial intelligence (AI) analysis to develop digital health solutions that may improve patient care, accelerate drug development, and further the understanding of the underlying pathologies of neurological diseases.

 

“We believe that neuroscience is at an inflection point for innovation and breakthrough. Advancements in technology may increase our ability to understand disease, target treatments, and manage risk,” said Martin Dubuc, Head of Biogen Digital Health. “Based on the outcome of our prior work with TheraPanacea and their success with AI in oncology, we are excited to further this collaboration. We believe digital health solutions will enable us to pioneer a new era of personalized medicine built upon a foundation of accessibility and precision.”

 

By harnessing ML and AI to draw meaning from medical imaging and other clinically relevant data sources, there is potential to improve disease understanding and enable more personalized clinical trial design. This could result in shortening drug development cycles, lowering associated costs, and increasing probability of success. At the same time, these digital health solutions have the potential to support more informed clinical decisions and could lead to improved health outcomes for patients.

 

“We are excited to collaborate with Biogen and combine our ML and AI solutions with their world-class clinical expertise and unique datasets in neuroscience,” said Professor Nikos Paragios, Chief Executive Officer of TheraPanacea and distinguished professor of mathematics at CentraleSupélec, University of Paris-Saclay. “Through this collaboration, we aim to scale our artificial intelligence multi-omics biomarker discovery platform and deploy clinical solutions that have the potential to deliver better treatment decisions for patients living with neurological diseases.”

 

Under the terms of the agreement, Biogen will invest up to $15 million in exchange for TheraPanacea convertible debt. The agreement also provides for up to approximately $41 million (based on current exchange rates) in milestone payments contingent upon the achievement of certain research and development milestones. In addition, Biogen gains exclusive rights to TheraPanacea’s technology in neuroscience. To meet the goals of this collaboration, TheraPanacea will invest in expanding its existing operations and workforce in Europe.

 

About Biogen

 

As pioneers in neuroscience, Biogen discovers, develops, and delivers worldwide innovative therapies for people living with serious neurological diseases as well as related therapeutic adjacencies. One of the world’s first global biotechnology companies, Biogen was founded in 1978 by Charles Weissmann, Heinz Schaller, Sir Kenneth Murray, and Nobel Prize winners Walter Gilbert and Phillip Sharp. Today, Biogen has the leading portfolio of medicines to treat multiple sclerosis, has introduced the first approved treatment for spinal muscular atrophy, and is providing the first and only approved treatment to address a defining pathology of Alzheimer’s disease. Biogen is also commercializing biosimilars and focusing on advancing the industry’s most diversified pipeline in neuroscience that will transform the standard of care for patients in several areas of high unmet need.

 

In 2020, Biogen launched a bold 20-year, $250 million initiative to address the deeply interrelated issues of climate, health, and equity. Healthy Climate, Healthy Lives™ aims to eliminate fossil fuels across the company’s operations, build collaborations with renowned institutions to advance the science to improve human health outcomes, and support underserved communities.

 

We routinely post information that may be important to investors on our website at www.biogen.com. Follow us on social media – TwitterLinkedInFacebookYouTube.

 

Biogen Safe Harbor

 

This news release contains forward-looking statements, including statements made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995, about the potential impact of machine learning/artificial intelligence with respect to clinical and health outcomes; the potential benefits from early identification of disease; the potential benefits and results that may be achieved through our collaboration with TheraPanacea; the potential of our commercial business and pipeline programs; and our strategy and plans. These statements may be identified by words such as “aim,” “anticipate,” “believe,” “could,” “estimate,” “expect,” “forecast,” “goal,” “intend,” “may,” “plan,” “possible,” “potential,” “will,” “would” and other words and terms of similar meaning. You should not place undue reliance on these statements, or the scientific data presented.

 

These statements involve risks and uncertainties that could cause actual results to differ materially from those reflected in such statements, including without limitation, the risks of unexpected costs or delays; the risk of other unexpected hurdles; failure to protect and enforce our data, intellectual property and other proprietary rights and uncertainties relating to intellectual property claims and challenges; regulatory authorities may require additional information or further studies; third party collaboration risks; and the direct and indirect impacts of the ongoing COVID-19 pandemic on our business, results of operations and financial condition. The foregoing sets forth many, but not all, of the factors that could cause actual results to differ from our expectations in any forward-looking statement. Investors should consider this cautionary statement as well as the risk factors identified in our most recent annual or quarterly report and in other reports we have filed with the U.S. Securities and Exchange Commission. These statements are based on our current beliefs and expectations and speak only as of the date of this news release. We do not undertake any obligation to publicly update any forward-looking statements, whether as a result of new information, future developments or otherwise.

 

 

About TheraPanacea

 

TheraPanacea is a highly innovative information technology company devoted to unlocking the unlimited power of AI-based solutions to drive innovation in healthcare.

 

Spinoff of University of Paris-Saclay, TheraPanacea works in close cooperation with the most prominent healthcare facilities to combine the power of its proprietary platforms with clinical domain-knowledge. Our technology is a unique combination of decisional, domain-constrained, and data-driven artificial intelligence software equipping clinicians and healthcare professionals with the most innovative tools to improve treatment selection, planning, delivery, and outcomes, including biomarker discovery and patient stratification.

 

Using TheraPanacea’s AI-powered clinical solutions (ART-Plan™), healthcare providers experience significant gain in productivity, higher standardization of care, improvement of clinical workflow and better treatment outcomes for cancer patients. TheraPanacea’s AI-powered biomarker discovery platform (ART-Omics™) offers upstream/downstream innovation to pharmaceutical companies through shorter development cycles, decreased costs and higher efficacy.

 

TheraPanacea’s development benefited from the ecosystems of University of Paris Saclay and Paris Biotech Santé while being backed by Therinvest, (Innothera’s independent growth digital health fund) and competitive fundings from the SATT Paris-Saclay, the French Ministry of Higher Education and Research, French Public investment Banque (BPI), the European Research Council (ERC) and the EIC Accelerator from the European Innovation Council.

UAVIA DEPLOYS ITS TECHNOLOGY WORLDWIDE

Article CF NEWS BY RODOLPHE LANGLOIS Published on 15 Dec 2021 at 14:49

 

Since 2018, and its first round of financing, the challenge for Uavia has been to demonstrate the usefulness of its technology to industry (see below). According to the publisher, which provides a collaborative platform for piloting autonomous and connected drones, it has achieved its goal, since the Total group, as part of a collaborative programme, has validated its interest in facilitating and securing the deployment of drones in order to capture data on their industrial sites. Its new ambition is now to “supply the major system integrators, to continue to find new use cases and to hand over our technologies to them, who can scale up to deployments for major clients”, confides Pierre Vilpoux, President of Uavia for the past two years. In this context, Uavia is raising €5m and inviting Innovacom and Cattleya Finance, the investment holding company of Benjamin & Ariane de Rothschild, to join its capital. The existing shareholders, UI Investissement and Bpifrance, who participated in the fundraising process, are taking advantage of the opportunity to reinject cash.

 

Validated economic model

 

One of the first recognised uses of the software platform is its ability to carry out remote missions. Uavia, which works with six to seven drone manufacturers, thus facilitates the piloting of surveillance, maintenance, verification or crisis management missions. “We have validated our business model. As a technology provider, we are going to hire system integrators worldwide who will represent the technology on the markets,” explains the manager. Our technologies allow us to take measurements directly inside the drone using our on-board intelligence, and to have real-time visualisations, such as for the search for pollutants on industrial sites. Uavia wants to offer end-users, particularly large groups in the energy, logistics or oil and chemical industry sectors, a unified and secure interface, with all configuration and usage settings being made via the software interface. The company, which will increase its workforce from 23 to 40 next year, is facing a market player such as the Swiss company Autérion.

 

The stakeholders of the UAVIA operation

 

Target company: UAVIA

Buyer or Investor : INNOVACOM , UI INVESTISSEMENT (EX UI GESTION) , BPIFRANCE INVESTISSEMENT , PERSON(S) PHYSICAL , Benjamin de Rothschild , Ariane de Rothschild

Purchaser Corporate Lawyer : JOFFE & ASSOCIES

Company Corporate Lawyer : FIDAL , Anne Fréchette-Kerbrat

 

Sea Vorian acquires Seafin, leader in high-tech products for the blue economy.

Article NEOTEK, published on 14 December 2021

 

Sea Vorian, a company created by a pool of investors led by Jean-Luc Biache and François-Xavier de Cointet, is acquiring 100% of Seafin, the leading distributor and manufacturer of high-tech products for the blue economy, from its founder Claude Pacheco, the Atalaya and Financière de Brienne 2 funds managed by Ace Capital Partners and the SFLD fund.

 

Founded in September 2004 by Claude Pacheco, Neotek specialises in the distribution and integration of data acquisition, oceanographic and hydrographic instrumentation, positioning, UAV and mine clearance equipment.

 

RTSys, acquired in 2012 when Ace Capital Partners funds entered the market, has established itself in the design and manufacture of underwater acoustics and robotics products. Its high level of expertise is now recognised in 4 main areas of innovation: passive acoustic monitoring (PAM), underwater exploration via autonomous underwater drones (AUV), mine countermeasures (MCM) and anti-submarine warfare (ASW).

 

Numerous R&D programmes have been carried out in partnership with the Directorate General for Armaments, the Pôles Mer de Compétitivité, or the European Defence Fund, to design miniaturised products without compromising either performance or cost. Renewable marine energies, deep sea exploration and anti-submarine warfare are all sectors in which the Seafin group now claims a leading position.

 

With the transfer of the group to Sea Vorian, a new stage is opening up for the Seafin group to become an undisputed European player in the naval, civil and defence submarine markets.

Translated with www.DeepL.com/Translator (free version)

GitGuardian secures two funds

Article CF NEWS BY RODOLPHE LANGLOIS Published on 7 Dec 2021 at 14:00

 

GitGuardian’s international dimension is set to grow further in the coming months. Born in 2017, this publisher of an automated detection solution for secrets hosted in the cloud has generated 75% of its revenues in the United States since its first round of funding in 2019, which has remained confidential (see below). The company, co-founded by Jérémy Thomas and already sponsored by Balderton Capital, Bpifrance and Germany’s Fly Ventures, is opening up directly to Eurazeo and Californian VC Sapphire Ventures in its series B round, which amounts to just over €39m ($44m). Alongside these two investors, who were also involved in Andjaro’s third round last year (see below), several of the company’s historical shareholders have taken the opportunity to strengthen their positions. Together, they value the Paris-based software publisher at just over €156m ($177m), three times more than two years ago. The whole process was quick,” says Jérémy Thomas, “since it took us a month to obtain our first term sheet. After that, we had to turn down proposals from five investment funds.

 

A first branch in the US

 

Within the source code security market, which is expected to reach between $50 and $100 billion by 2025, GitGuardian operates in a niche vertical, DevSecOps, estimated at $10 billion, i.e. the automated detection and identification of leaks of sensitive authentication data processed daily by developers. Its international clients include Talend, Mirantis, Instacart, Genesys, Now:Pensions and Maven Wave, “which spent an average of $140K this year,” adds the executive. We are the number one source code security application on GitHub in terms of number and installation, with 130,000 downloads.” The company, which employs 60 people, wants to take advantage of its funding to add other types of vulnerability, and thus move into adjacent verticals by 2022, which form a “very fragmented” market, in which the Israeli start-up Checkmarx, in particular, is operating. GitGuardian should also open its first foreign office next year, with the creation of an office in Texas, headed by Jérémy Thomas. The publisher could also launch a recruitment campaign for a hundred people by 2022.

 

Philips to expand its cardiac diagnostics and monitoring portfolio with the acquisition of Cardiologs

Read the Article on Philips’ website 

 

Amsterdam, the Netherlands – Cardiologs will further strengthen Philips’ cardiac monitoring and diagnostics offering with innovative software technology, electrocardiogram (ECG) analysis and reporting services. The transaction, which is subject to customary closing conditions, is expected to be completed in the coming months. Financial details of the transaction were not disclosed.

 

The acquisition of Cardiologs is a strong fit with Philips’ existing portfolio of cardiac care solutions. This includes real-time patient monitoring, therapeutic devices, telehealth and informatics for the hospital, as well as ambulatory cardiac diagnostics and monitoring solutions, that were added through the recent acquisition of BioTelemetry, Inc.

 

Cardiologs will complement this offering with a vendor-neutral heart disorder screener and ECG analysis applications, based on machine learning algorithms. Developed in partnership with leading physicians, Cardiologs’ technology accelerates diagnostic reporting, decreases the occurrence of reporting errors and streamlines clinician workflow and patient care, empowering clinicians to deliver expert cardiac care faster and more efficiently. CE-marked and FDA cleared for detection of cardiac arrhythmias, Cardiologs’ technology is built on a growing database of more than 20 million ECG recordings and supported by a number of clinical publications.

Offering superb clinical insights, as well as automated clinical reporting, Cardiologs’ medical-grade AI technology and data scientists will be a strong addition to our growing portfolio of cardiac solutions for hospital and ambulatory settings.
Roy Jakobs

 

“Offering superb clinical insights, as well as automated clinical reporting, Cardiologs’ medical-grade AI technology and data scientists will be a strong addition to our growing portfolio of cardiac solutions for hospital and ambulatory settings,” said Roy Jakobs, Chief Business Leader Connected Care at Royal Philips.

 

Philips’ global footprint can accelerate the availability of Cardiologs’ technology to patients all over the world and further deliver on the quadruple aim of an improved patient care experience, better health outcomes, improved staff experience, and lower cost of care.”

 

“We are delighted to become part of Philips and continue innovating together to provide solutions that empower clinicians all around the world,” said Yann Fleureau, Co-Founder and CEO of Cardiologs. “We look forward to the opportunity to expand the business as part of Philips, maintaining vendor neutrality and continuing to work with third party vendors to drive further adoption of digital health solutions globally.”

 

Cardiologs was founded in 2014 and is headquartered in Paris, France. Its approximately 70 employees, largely comprising software engineers and data scientists with expertise in AI and deep learning algorithms, will join Philips and will expand the company’s continued AI-focused innovation activities together with the company’s R&D lab in Paris. Philips has a strong presence in France, consisting of research and development activities, as well as sales, marketing and distribution at multiple sites.

Gardengate opens to a second fund

CFNEWS Article BY AURORE BARLIER Published on 18 Oct 2021 at 10:15

 

With 85% of its €90m in revenues generated in France, what could be more natural for Portuguese company Gardengate than to choose a team based in the Hexagon to accompany it in its new growth phase. After two years in the portfolio of its compatriot Crest Capital, the aluminium doors manufacturer has joined Equistone. Equistone, selected after a competitive process organised by the Portuguese teams of PwC, acquires a stake of about two thirds of the capital, alongside the founder and management. The fund is intervening here via its Equistone VI vehicle, which, with an investment of almost 50%, would inject equity in the middle of its range (between €25 and €200 million) in this transaction. The former majority shareholder will reinvest a portion of its proceeds to retain a minority stake. This LBO bis is completed by a unitranche debt provided by Eurazeo IM (ex-Idinvest), with the support of the Portuguese private debt fund Tresmares Capital.

 

Conquering Europe

 

Founded in 1997 in Braga under the initial name Porta XXI, Gardengate distributes its products (gates, fences, shutters, fences, etc.) under the Portadeluxe, Greendoor and Friday Courage brands, mainly through DIY stores. This distribution channel has naturally led to a strong presence in France, which is “by far the largest European market for aluminium closures,” say Equistone partners Grégoire Châtillon and Thierry Lardinois. And the group of 600 employees led by its founder, Adelino Costa, now intends to diversify its geographies by relying on the European network of its new majority owner (represented in the Netherlands, England, Paris and Germany). The aim is to increase its presence in areas where it is not very present, such as the Benelux countries, Germany and the United Kingdom – markets that are less mature than France and which offer significant growth potential. In this context, Gardengate will be able to capitalize on the natural geographic expansion of its partner DIY stores, and will support it with new online offerings and expanded product lines.

 

18% annual growth

 

In addition to these commercial developments, the company intends to consolidate its local production units – of which there are currently nine – onto a single site in order to increase its production capacity and improve its profitability. All this in a context of continued growth, averaging 18% per year between 2016 and 2021. “Despite supply difficulties and the closure of certain DIY stores during the lockdowns, the company continued to grow in 2020, thanks in particular to the importance that individuals have placed on their living environment since the crisis,” say Grégoire Châtillon and Thierry Lardinois, adding that the planets seem to be fully aligned to continue this dynamic: “Aluminium products continue to take market share from wood, PVC or steel products. At the same time, distribution via online channels and DIY stores is gaining ground on installers,” the investors continue, commenting on a sector they know well having accompanied La Toulousaine between 2010 and 2015 (see below).

 

The stakeholders in the GARDENGATE transaction

 

  • Target company: GARDENGATE
  • Buyer or Investor : EQUISTONE PARTNERS, Grégoire Châtillon , Thierry Lardinois , Jérémy Mathis , Valérian Fleury , FOUNDER(S), Adelino Costa , MANAGERS
  • Transferor : CREST CAPITAL PARTNERS, FOUNDER(S), Adelino Costa , MANAGERS
  • Acquirer Investment banker / M&A advisor : BANCO FINANTIA
  • Business lawyers Financing: GOODWIN, Adrien Paturaud , Laurent Bonnet.
  • Competition Lawyer: JOFFE & ASSOCIES, Olivier Cavézian , Klara Matous
  • DD Legal and Tax: GOODWIN, Thomas Maitrejean , Marie-Laure Bruneel , Simon Servan-Schreiber , Arthur Deschamps , CMS RUI PENA & ARNAUT
  • DD Financial : EIGHT ADVISORY, Stéphane Vanbergue , Christophe Puissegur , Julien Roux.
  • DD Strategic : ROLAND BERGER, Ambroise Lecat , Sébastien Murbach , Matthieu Daumas , Mouhsine Aguedach
  • Transferor Investment Banker / M&A Advisor: PWC CORPORATE FINANCE
  • Transferor Corporate lawyer: GARRIGUES
  • Legal and tax advisor: GARRIGUES
  • VDD Financial: KPMG TS
  • Transferor Strategic advice: LEK CONSULTING, Serge Hovsepian , Maxime Julian
  • Debt: TRESMARES CAPITAL
  • Debt Unitranche: EURAZEO IM (EX IDINVEST PARTNERS), Maxime de Roquette Buisson
  • Debt Lawyer: MAYER BROWN, Patrick Teboul
  • Financing Counsel: MARLBOROUGH PARTNERS, Romain Cattet , Philippe de Courrèges

AI VERSE VISUALISES ITSELF

CF NEWS Article , BY LUCAS DJEFFAL Published on 18 Oct 2021 at 10:20

The young deeptech company AI Verse wants to democratize the use of deep learning (software that simulates a neural network, commonly known as artificial intelligence – AI) for the creation of artificial vision software. To do this, it is tackling the lack of images and more specifically the lack of correctly labelled images, i.e. where each pixel of an important element in an image is identified, which is essential for training an AI. “Only large organisations can afford to rally the resources needed to build a bank of labelled images manually and without being able to predict the final quality,” comments Benoit Morisset, president and founder in 2020. A doctor in robotics and artificial intelligence, he founded Pixmap, a company that integrates 3D mapping systems with robotics. With Arnaud Lamorlette, an expert in 3D animation who has supervised Dreamworks projects (Shrek 2 and 3, etc.), they have developed a solution that automatically generates synthetic images that can feed these digital neural networks. To finalise it, they raised €2.5m from Innovacom, which is involved through its Technocom 3 FPCI and the Digital Venture fund of Bpifrance Investissement. The five current employees (excluding the founder) also hold 20% of the shares.

 

Sale of image banks

The new cash will enable the software to be taken from the prototype stage to a marketable solution within twelve to sixteen months. It will be available through an online platform and will be aimed at SMEs as well as large accounts in the fields of robotics, virtual and augmented reality, home automation, smart cities and intelligent assistants. IA Verse, based near Nice, promises that each client will be able to obtain in a few hours a bank of computer-generated images representing any situation, on which an AI must be trained, for a price of around ten cents per image. Five to ten tech profiles should thus be recruited. The American companies DataGem and Parallel Domain, which specialises in imaging for autonomous vehicles, are present in the sector. In France, the company Imageens – which raised €1.2m in April (see below) – has developed software that automatically defines the elements present in existing medical images.

 

The stakeholders in the AI VERSE transaction

  • Target company: AI VERSE
  • Buyer or Investor: INNOVACOM, BPIFRANCE INVESTISSEMENT
  • Corporate Counsel: CONSTELLATION AVOCATS, Pierre Callède
  • Investor Counsel: JOFFE & ASSOCIES, Thomas Saltiel, Charlotte VIANDAZ

Makuity joins the Heroiks group

Heroiks acquires the independent media agency Makuity, created in 1985 under the name Promopress Media, and headed by Gérard Kisler. The agency manages 60 million euros of annual investment and has about 20 experts.

For Heroiks, this acquisition also presents the interest of strengthening its position in the management of public tenders managed by Makuity, such as local authorities (City of Paris, Grand Est Region, Burgundy Franche-Comté Region, Vendée Departmental Council, etc.), inter-professional bodies (Nouveau by Beaujolais, Union des Industries de la Protection des Plantes, etc.), public organisations (Caisse Nationale des Allocations Familiales, Caisse Nationale d’Assurance Vieillesse, Pôle Emploi, etc.). ..).

ServiceNow acquires Mapwize

Article by Legal Global Chronicle France, Published October 14, 2021

 

With Mapwize, ServiceNow will provide indoor mapping features to employees as they book conference rooms and workspaces from their computers or mobile devices, as well as as as they move around the company’s premises.

Mapwize’s features will also help workplace teams manage space plans based on usage trends and changing real estate needs. To support flexible and agile workplaces, ServiceNow intends to integrate Mapwize features into the Now Platform and the Workplace Service Delivery suite. Mapwize’s mapping solutions, product features and engineers will complement and enhance ServiceNow’s existing Workplace Service Delivery services, including Workplace Space Mapping, Workplace Reservation Management, Workplace Space Management, Workplace Visitor Management, Case and Knowledge Management and Safe Workplace Suite.

 

ServiceNow was primarily advised in this acquisition by Baker McKenzie, led by the Paris-based firm’s team of Guillaume Nataf (Photo) , Partner, Samantha Chavane de Dalmassy, Associate, Paul Nury, Associate, Johanna Federspiel, Counsel, Denise Broussal, Partner, Nadège Dallais, Partner, Lauriane Raux, Associate, Adrien Leberon, Associate, For tax matters, Stéphane Taïeb, Associate, Robin Gaulier, Associate, Nathalie Marchand, Partner, Audrey Bovie, Associate, Magalie Dansac le Clerc, Partner, Bérénice de Wailly, Associate, Léna Sersiron, Associate, Manuella Roblet, Associate, Arnaud Cabanes, Associate, Christophe de Saint-Pern, Associate.

Baker McKenzie’s Santa Clara, California office also participated in the transaction with Derek Liu, Partner and Dominique Manguiat, Associate.

 

Joffe & Associés advised Mapwize with a team composed of Thomas Saltiel, Partner, Paddy Pascot and Charlotte Viandaz, Associates.

Creation of Nomadia, French champion of SaaS solutions for drifter professionals

Article by Nomadia Group, published

 

Nomadia symboliss the entrepreneurial dynamics of tech in France and aims to promote local know-how at an international level.

 

Nomadia is the result of the merger of three renowned French software publishers with complementary expertise in the field of mobility: GEOCONCEPT (route and schedule optimisation, field service management, GIS and geomarketing), DANEM (mobile business applications for sales representatives, delivery drivers and technicians) and B&B Market (CRM SFA, consulting and data for the consumer goods and retail industries).

 

Operating in a market that is growing by 15% per year and is expected to exceed 30 billion euros by 2026, Nomadia responds to the growing need of companies to manage the activities of their professionals in the field in real time. These professionals, who spend an average of 30% of their working time on the road, share the need to optimise the management of their interventions to gain operational efficiency and improve customer satisfaction. This need has increased since the beginning of the pandemic, with a hybrid work organisation and, above all, new requirements for connectivity to access data everywhere and at all times.

 

Operational gains and a CSR asset

 

Through advanced optimisation algorithms, mobile business applications, sales cycle automation capabilities, and data and consulting offerings, Nomadia’s solutions help companies address their key operational performance and profitability challenges with a promise of 20% productivity gains.

 

In addition, Nomadia’s solutions address the increasing attention companies are paying to their environmental footprint (with a reduction in CO2 emissions of up to 30% for users of route optimisation solutions) and employee well-being (scheduling optimisation tools that take into account employee constraints in the distribution of missions).

 

The Nomadia group’s 1,500 customers have already been able to take advantage of all these benefits, whether in logistics with Colis Privé or Cdiscount, in energy with Engie, GRDF, Dalkia or Suez, in healthcare with Johnson&Johnson or Pfizer, in industry with Otis or Veolia, and in all other sectors with mobile professionals, from small and medium-sized businesses to large corporations.

 

Growth ambitions in France and internationally

 

By establishing itself as a new French champion of mobility with a rich catalog of complementary solutions for mobile professionals, Nomadia enjoys a unique positioning, industry recognition (in 2021 hailed for the 4th time in a row by Gartner in its FSM Magic Quadrant) and a first-rate customer portfolio that will enable it to win new market share in France and accelerate its growth at an international scale, particularly in Europe and the United States.

 

Reunited since the beginning of the summer, the three companies have already initiated the first steps of their integration in order to rapidly leverage their commercial and technological synergies. In September 2021, the brands of the three combined players will change. They will be complemented by the words “by Nomadia” to gradually become a single commercial brand: Nomadia.

 

“The creation of a new leader is excellent news and a strength for our customers. We are now offering them a common and enhanced platform to benefit from leading solutions for the management of their critical missions in the field. This combination of three technological gems is also a vector for the dissemination of French know-how as well as an innovation gas pedal, leading to an offer capable of competing with solutions that until now have only been offered by major international publishers. With Nomadia, mobility becomes an asset and no longer a constraint.”

Fabien Bréget, CEO and founder of Nomadia

 

Nomadia has 170 employees, more than a third of whom are dedicated to research and development. The group is clearly committed to innovation, with many projects coming, particularly in the fields of electro-mobility, IoT, Artificial Intelligence and Machine Learning, augmented reality and Industry 4.0 (augmented technician).

 

About GEOCONCEPT by Nomadia

 

For 30 years, GEOCONCEPT, a French publisher of geographic optimisation software solutions for professionals, has been a world leader in field service planning and route optimisation. Recognised as a major player in Field Service Management and Vehicle Routing & Scheduling by Gartner, GEOCONCEPT optimises the daily movements of 155,000 resources worldwide.

 

GEOCONCEPT has offices in Paris, Grenoble and Caen, and offices in the United States, China, India and Switzerland. GEOCONCEPT’s solutions are also resold by strategic partners in many countries, including the United Kingdom, Mexico, Brazil and Japan.

 

About Danem by Nomadia

 

Since 1996, Danem has been the specialist in nomadic business solutions and applications. A true French pioneer in IT mobility, the publisher designs and markets mobility solutions for mobile staff to optimise relations with customers, field teams and headquarters. More than 300 companies and more than 12,000 people use the complete software and hardware solutions of the Ile-de-France-based company every day. Through its business applications, Danem offers solutions for taking orders, distributing and tracking packages, managing and planning technicians’ interventions, and even selling on a drop-off basis.

 

Danem is based in France, but also distributes its solutions in French-speaking African countries and in Europe (Belgium, Italy, etc.).

 

About B&B Market by Nomadia

 

Since 1991, B&B Market has been a key Frenchactor, a specialised publisher of CRM SFA solutions and customised services dedicated to the consumer goods and distribution sector: Audit, Consulting (Sales organisation and optimisation, business data supply, etc.). More than 100 companies and 2,300 sales representatives use its solutions every day.

 

Structured around a double expertise, Consulting/Data and CRM SFA, B&B Market accompanies and advises Sales Departments in the processing and analysis of their commercial data, in the rationalisation of their sales force and in the improvement of operational productivity with powerful tools and Business Intelligence.

 

Joffe & Associés advised BPI France with a team composed of Thomas Saltiel, partner, and Johann Mendez, associate.